Co-Dx and CoSara inaugurate oligo synthesis facility in Ranoli, India
Co-Dx and our Indian joint venture, CoSara Diagnostics Pvt. Ltd, inaugurated the oligonucleotide synthesis facility in Ranoli, India on December 11, 2024. The new facility is designed to support the “Make in India” initiative by manufacturing our patented Co-Primers® chemistry, which has been used in the Co-Dx and CoSara lab-based PCR tests for years, and will also power the test cups for the upcoming Co-Dx PCR at-home and POC testing platform.*
